SG11202103001PA - Hmgb1 protein derivatives for the removal of biofilms cross-reference to related application - Google Patents

Hmgb1 protein derivatives for the removal of biofilms cross-reference to related application

Info

Publication number
SG11202103001PA
SG11202103001PA SG11202103001PA SG11202103001PA SG11202103001PA SG 11202103001P A SG11202103001P A SG 11202103001PA SG 11202103001P A SG11202103001P A SG 11202103001PA SG 11202103001P A SG11202103001P A SG 11202103001PA SG 11202103001P A SG11202103001P A SG 11202103001PA
Authority
SG
Singapore
Prior art keywords
removal
related application
protein derivatives
hmgb1 protein
biofilms
Prior art date
Application number
SG11202103001PA
Inventor
Steven Goodman
Lauren Bakaletz
Original Assignee
Res Inst Nationwide Childrens Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Res Inst Nationwide Childrens Hospital filed Critical Res Inst Nationwide Childrens Hospital
Publication of SG11202103001PA publication Critical patent/SG11202103001PA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1228—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K16/1232—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia from Escherichia (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Transplantation (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
SG11202103001PA 2018-10-05 2019-10-04 Hmgb1 protein derivatives for the removal of biofilms cross-reference to related application SG11202103001PA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862742102P 2018-10-05 2018-10-05
PCT/US2019/054851 WO2020072993A1 (en) 2018-10-05 2019-10-04 Hmgb1 protein derivatives for the removal of biofilms cross-reference to related application

Publications (1)

Publication Number Publication Date
SG11202103001PA true SG11202103001PA (en) 2021-04-29

Family

ID=70054912

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202103001PA SG11202103001PA (en) 2018-10-05 2019-10-04 Hmgb1 protein derivatives for the removal of biofilms cross-reference to related application

Country Status (12)

Country Link
US (1) US20210340198A1 (en)
EP (1) EP3860718A4 (en)
JP (1) JP2022504139A (en)
KR (1) KR20210070331A (en)
CN (1) CN112823038A (en)
AU (1) AU2019354829A1 (en)
BR (1) BR112021006321A2 (en)
CA (1) CA3114905A1 (en)
IL (1) IL281720A (en)
MX (1) MX2021003838A (en)
SG (1) SG11202103001PA (en)
WO (1) WO2020072993A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2018236271B2 (en) 2017-03-15 2023-12-21 Research Institute At Nationwide Children's Hospital Composition and methods for disruption of bacterial biofilms without accompanying inflammation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003295653B2 (en) * 2002-11-20 2007-08-16 The Feinstein Institute Of Medical Research Use of HMGB polypeptides for increasing immune responses
EP1569684A4 (en) * 2002-11-20 2006-08-02 Critical Therapeutics Inc Use of hmgb fragments as anti-inflammatory agents
CN103097399A (en) * 2010-03-29 2013-05-08 南加利福尼亚大学 Compositions and methods for the removal of biofilms
WO2014016417A1 (en) * 2012-07-26 2014-01-30 Ospedale San Raffaele Srl Hmgb1 variants and uses thereof
US20160194384A1 (en) * 2014-06-12 2016-07-07 Research Institute At Nationwide Children's Hospital Compositions and methods for the removal of biofilms
AU2018236271B2 (en) * 2017-03-15 2023-12-21 Research Institute At Nationwide Children's Hospital Composition and methods for disruption of bacterial biofilms without accompanying inflammation

Also Published As

Publication number Publication date
WO2020072993A1 (en) 2020-04-09
EP3860718A4 (en) 2022-08-31
JP2022504139A (en) 2022-01-13
EP3860718A1 (en) 2021-08-11
US20210340198A1 (en) 2021-11-04
KR20210070331A (en) 2021-06-14
CA3114905A1 (en) 2020-04-09
IL281720A (en) 2021-05-31
AU2019354829A1 (en) 2021-04-29
MX2021003838A (en) 2021-05-27
BR112021006321A2 (en) 2021-07-06
CN112823038A (en) 2021-05-18

Similar Documents

Publication Publication Date Title
EP3929197C0 (en) Intermediates for the synthesis of microbiocidal heterobicyclic derivatives
IL286592A (en) Amino acid compositions for the treatment of liver disease
IL279592A (en) Substituted heterocycle fused gamma-carbolines synthesis
IL276592A (en) Derivatives of sobetirome
GB2575261B (en) Intermediates in the synthesis of C3-substituted cephalosporins
IL276483A (en) Continuous process for the preparation of trazodone
ZA202000498B (en) Purification of tobacco-derived protein compositions
IL291221A (en) Processes for the synthesis of valbenazine
IL283959A (en) Substituted heterocycle fused gamma-carbolines synthesis
ZA202004466B (en) Processes for the synthesis of sulfentrazone
SG11202103001PA (en) Hmgb1 protein derivatives for the removal of biofilms cross-reference to related application
IL283963A (en) Substituted heterocycle fused gamma-carbolines synthesis
IL279410A (en) Process for the preparation of quinmerac
IT201900025186A1 (en) Method for the purification of cysteamine
PT3759082T (en) Process for the synthesis of 6-chloromethyluracil
GB201804905D0 (en) Cataltic synthesis of biarylic compounds
IS2977B (en) Process for the preparation of intermediates useful in the synthesis of eluxadoline
GB201820685D0 (en) Synthesis of 8-chloroadenosine derivatives
PL3713939T3 (en) Improved process for the synthesis of linker-drug vc-seco
GB201807468D0 (en) Methods of synthesis
UA40769S (en) DESIGN FOR THE FRONT PART OF THE MULTI-COOKER
GB201809404D0 (en) Method of synthesis
IT201600129605A1 (en) COMPOSITION FOR THE TREATMENT OF MUSCLE-SKELETAL PATHOLOGIES
IT201700054488A1 (en) COMPOSITION FOR THE TREATMENT OF SKIN INFLAMMATORY FORMS
SI3320102T1 (en) Method for the synthesis of pentostatin